NU-MED PLUS INC (NUMD) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NUMD SEC filings page.
This page shows NU-MED PLUS INC (NUMD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Balance-sheet contraction dominates: liabilities rise while assets and near-term liquidity shrink, leaving financing increasingly disconnected from the asset base.
By FY2025, liabilities had nearly doubled from FY2022 while total assets had contracted sharply, leaving negative equity more than four times deeper. The current ratio fell from 0.6x to 0.0x, showing that short-term obligations are increasingly unsupported by stated current assets.
In FY2022, net loss of
Operating cash flow moved from
Financial Health Signals
NU-MED PLUS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
NU-MED PLUS INC generated $0 in revenue in Q2 2026.
NU-MED PLUS INC's EBITDA was -$23K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 116.5% from the same quarter a year earlier. Against the prior quarter it is down 71.5%.
NU-MED PLUS INC reported $20K in net income in Q2 2026. This represents an increase of 268.6% from the same quarter a year earlier. Against the prior quarter it is up 223.9%.
Cash & Balance Sheet
NU-MED PLUS INC held $5K in cash against $0 in long-term debt as of Q2 2026, with $280K of liabilities due within a year.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
NUMD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | N/A | $0 | $0 | N/A | N/A | N/A |
| SG&A Expenses | $8K+47.6% | $5K-15.3% | N/A | $5K | $6K-4.7% | N/A | $9K+7.0% | N/A |
| Operating Income | -$23K-116.5% | -$13K+29.7% | N/A | -$10K | -$19K+9.1% | N/A | -$17K-15.0% | N/A |
| EBITDA | -$23K-116.5% | -$13K+29.7% | N/A | -$10K | -$19K | N/A | N/A | N/A |
| Interest Expense | $3K+122.6% | $3K+121.2% | N/A | $1K | $1K-1.1% | N/A | $1K0.0% | N/A |
| Income Tax | $0 | $0 | N/A | $0 | N/A | N/A | N/A | N/A |
| Net Income | $20K+268.6% | -$16K+20.3% | N/A | -$12K+32.5% | -$20K+8.7% | N/A | -$19K-13.8% | -$17K+28.9% |
| EPS (Basic) | $0.00 | $0.00 | N/A | $0.00 | $0.00 | $0.00 | $0.00 | N/A |
| EPS (Diluted) | $0.00 | N/A | N/A | $0.00 | N/A | $0.00 | $0.00 | N/A |
| Diluted Shares (Avg) | 84M0.0% | 84M0.0% | N/A | 84M | 84M0.0% | N/A | 81M0.0% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
NUMD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13K | $7K | $8K-15.6% | N/A | N/A | $9K-30.3% | $7K-50.2% | N/A |
| Current Assets | $13K | $7K | $8K-15.6% | N/A | N/A | $9K-30.3% | $7K-50.2% | N/A |
| Cash & Equivalents | $5K+526.8% | $4K+80.5% | $661-72.1% | $863 | $2K-62.7% | $2K-65.1% | $4K-63.6% | N/A |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A |
| Total Liabilities | $280K | $294K | $279K+24.4% | N/A | N/A | $224K+40.1% | $211K+45.1% | N/A |
| Current Liabilities | $280K | $294K | $279K+24.4% | N/A | N/A | $224K+40.1% | $211K+45.1% | N/A |
| Non-Current Liabilities | $0 | $0 | $0 | N/A | N/A | $0 | $0 | N/A |
| Long-Term Debt | $0 | $0 | $0 | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$267K-8.4% | -$287K-22.2% | -$271K-26.1% | -$247K-32.7% | -$235K-39.4% | -$215K-46.6% | -$205K-55.0% | -$186K-60.9% |
| Retained Earnings | -$9.9M | -$10.0M | -$9.9M-0.6% | N/A | N/A | -$9.9M-0.7% | -$9.9M-1.2% | N/A |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.
NUMD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
NUMD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Note: Shareholder equity is negative (-$271K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where NU-MED PLUS INC Ranks
Frequently Asked Questions
How much debt does NU-MED PLUS INC have?
As of fiscal year 2025, NU-MED PLUS INC (NUMD) had $661 in cash and equivalents against $0 in long-term debt.
What are NU-MED PLUS INC's total assets?
NU-MED PLUS INC (NUMD) had $8K in total assets as of fiscal year 2025, including both current and long-term assets.
What is NU-MED PLUS INC's current ratio?
NU-MED PLUS INC (NUMD) had a current ratio of 0.03 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Why is NU-MED PLUS INC's debt-to-equity ratio negative or not reported?
NU-MED PLUS INC (NUMD) has negative shareholder equity of -$271K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.